Stephen Uden
Patrimonio netto: 2 M $ in data 31/08/2026
Patrimonio netto: 2 M $ in data 31/08/2026
Dr. Stephen Uden, MD, is a President, Chief Executive Officer & Director at Rallybio Corp.
and a President, Chief Executive Officer & Director at Rallybio LLC.
He is on the Board of Directors at Rallybio Corp.
and Rallybio LLC.
Dr. Uden was previously employed as a Senior Vice President-Research by Alexion Pharmaceuticals, Inc. and a Head-Research & Development by Neurogen Corp.
He received his undergraduate degree from the University of London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RALLYBIO CORPORATION 1,73% | 19/12/2025 | 91.920 ( 1,73% ) | 2 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RALLYBIO CORPORATION | Fondatore | 01/01/2018 |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Fondatore | 01/01/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Direttore Tecnico/Scientifico/R&S | 14/09/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale